| [1] |
Kawada T, Yamamoto H, Yokoi A, et al. Acute effects of empagliflozin on open-loop baroreflex function and urine glucose excretion in Goto-Kakizaki diabetic rats [J]. J Physiol Sci, 2023, 73(1): 7.
|
| [2] |
Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes [J]. N Engl J Med, 2015, 373(22): 2117-2128.
|
| [3] |
Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction [J]. N Engl J Med, 2021, 385(16): 1451-1461.
|
| [4] |
Shen J, Lai Y, Lu Y, et al. NRF2-HIF2alpha signaling attenuates endothelial cell senescence and maintains intercellular junctions in diabetes [J]. Int J Biol Sci, 2024, 20(10): 4055-4073.
|
| [5] |
Huang Y, Wang J, Jiang C, et al. ANXA2 promotes osteogenic differentiation and inhibits cellular senescence of periodontal ligament cells (PDLCs) in high glucose conditions [J]. PeerJ, 2024, 12: e18064.
|
| [6] |
Matacchione G, Valli D, Silvestrini A, et al. Curcumin, polydatin and quercetin synergistic activity protects from high-glucose-induced inflammation and oxidative stress [J]. Antioxidants (Basel), 2022, 11(6): 1037.
|
| [7] |
Zhou Y, Wang D, Xiao Q, et al. Spermidine alleviates diabetic periodontitis by reversing human periodontal ligament stem cell senescence via mitophagy [J]. Free Radic Biol Med, 2025, 227: 379-394.
|
| [8] |
Lu J, Sun W, Liu B, et al. Chk2 modulates Bmi1-deficiency-induced renal aging and fibrosis via oxidative stress, DNA damage, and p53/TGFbeta1-induced epithelial-mesenchymal transition [J]. Int J Biol Sci, 2024, 20(6): 2008-2026.
|
| [9] |
Herranz N, Gil J. Mechanisms and functions of cellular senescence [J]. J Clin Invest, 2018, 128(4): 1238-1246.
|
| [10] |
Wang H, Yu X, Liu D, et al. VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2/HO-1 signaling pathway in diabetic nephropathy [J]. Adv Sci (Weinh), 2024, 11(10): e2305563.
|
| [11] |
Kim S, Kang SW, Joo J, et al. Characterization of ferroptosis in kidney tubular cell death under diabetic conditions [J]. Cell Death Dis, 2021, 12(2): 160.
|
| [12] |
Chen J, Liu D, Lei L, et al. CNPY2 aggravates renal tubular cell ferroptosis in diabetic nephropathy by regulating PERK/ATF4/CHAC1 pathway and MAM integrity [J]. Adv Sci (Weinh), 2025, 12(25): e2416441.
|
| [13] |
Wei X, Liu M, Zheng Z, et al. Defective NCOA4-dependent ferroptosis in senescent fibroblasts retards diabetic wound healing [J]. Cell Death Discov, 2023, 9(1): 138.
|
| [14] |
Wei X, Zheng Z, Liu M, et al. Enzyme-responsive nanospheres target senescent cells for diabetic wound healing by employing chemodynamic therapy [J]. Acta Biomater, 2023, 172: 407-422.
|
| [15] |
Dao JJ, Zhang W, Liu C, et al. Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway [J]. Front Pharmacol, 2025, 16: 1528604.
|
| [16] |
Fan J, Xue L, Lin H, et al. Depletion of NUAK2 blocks the stemness and angiogenesis and facilitates senescence of lung adenocarcinoma cells via enhancing ferroptosis [J]. Cell Div, 2024, 19(1): 23.
|
| [17] |
Li S, Wang M, Wang Y, et al. p53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells [J]. Toxicol In Vitro, 2021, 73: 105146.
|
| [18] |
Pan C, Li S, Liu T, et al. Adolescent exposure to polylactic acid microplastics causes cardiac fibrosis by promoting cardiomyocyte senescence [J]. Toxicology, 2026, 519: 154318.
|
| [19] |
Wang X, Wang K, Mao W, et al. Emerging perfluoroalkyl substances retard skeletal growth by accelerating osteoblasts senescence via ferroptosis [J]. Environ Res, 2024, 258: 119483.
|
| [20] |
Lu Q, Yang L, Xiao JJ, et al. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway [J]. Free Radic Biol Med, 2023, 195: 89-102.
|
| [21] |
Jesus EF, Luchi WM, Castro PC, et al. SGLT2 inhibitors blunt kidney magnesium wasting in acute cisplatin-induced hypomagnesemia with effects on the thick Ascending limb and distal convoluted tubule [J]. J Am Soc Nephrol, 2025, 36(9): 1689-1701.
|
| [22] |
Kodama G, Taguchi K, Ito S, et al. Glucagon like peptide-1 modulates urinary sodium excretion in diabetic kidney disease via ENaC activation [J]. Sci Rep, 2025, 15(1): 11486.
|
| [23] |
Onishi A, Fu Y, Patel R, et al. A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin [J]. Am J Physiol Renal Physiol, 2020, 319(4): F712-F728.
|
| [24] |
Bahena-Lopez JP, Rojas-Vega L, Chavez-Canales M, et al. Glucose/fructose delivery to the distal nephron activates the sodium-chloride cotransporter via the calcium-sensing receptor [J]. J Am Soc Nephrol, 2023, 34(1): 55-72.
|
| [25] |
Ishizawa K, Wang Q, Li J, et al. Inhibition of sodium glucose cotransporter 2 attenuates the dysregulation of Kelch-like 3 and NaCl cotransporter in obese diabetic mice [J]. J Am Soc Nephrol, 2019, 30(5): 782-794.
|